20.500.12556/DiRROS-8666 Zavorno in nadomestno zdravljenje s ščitničnimi hormoni Suppressive and Substitution Therapy with Thyroid Hormones A patient with papillary or follicular thyroid carcinoma and unfavorable prognostic factors should have low serum TSH level in order to diminish the risk of recurrence. However, in order to prevent side effects on target organs (heart, bones), the levels of thyroid hormones should be inside the normal reference range. Whenever the thyroid doesn't produce enough hormones in a patient with a benign thyroid disease, the patient should be treated with a hormone replacement therapy. The aim of the substitution therapy is that TSH, free T4 and free T3 are inside the normal reference ranges. Bioequivalence of different generic drugs with thyroxin may differ from 12.5 to 25%. Therefore, if one thyroxine drug is changed with another one, a laboratory test of TSH level has to be performed after six weeks. true false true Slovenski jezik Angleški jezik by Authors Neznano 2018-08-31 13:27:50 2018-08-31 13:27:50 2022-08-16 10:11:52 0000-00-00 00:00:00 2008 0 0 str. 33-34 št. 1 Letn. 12 jun. 2008 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616-006 1408-1741 URN:NBN:SI:doc-88Y0MQWP 619131 65324032 RAZ_Besic_Nikola_i2008.pdf RAZ_Besic_Nikola_i2008.pdf 1 AF30B70E76FDDD45C5DBA0170AAC0703 6154558a1512ad20529919c0f1a5cb3dfece82942481c9b3f00616d5eba92d1b 56380b71-17b5-11ed-b6b8-001a4af901a5 20.500.12556/dirros/5d124fdf-7174-425d-a132-4371e93f53a7 https://dirros.openscience.si/Dokument.php?lang=slv&id=10447 Onkološki inštitut Ljubljana Onkologija : strokovni časopis za zdravnike 0 0 0